Moving beyond immunoglobulin therapy for CIDP with efgartigimod
Nat Rev Neurol
.
2024 Nov 28.
doi: 10.1038/s41582-024-01045-8.
Online ahead of print.
Author
Jan D Lünemann
1
Affiliation
1
Department of Neurology with Institute of Translational Neurology, University and University Hospital of Münster, Münster, Germany. jan.luenemann@ukmuenster.de.
PMID:
39609632
DOI:
10.1038/s41582-024-01045-8
No abstract available